Experiment 1267006

Worktypes

EFFECTS DUE TO A COMBINATION OF DRUGSANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF EXTRACT - IN HUMANSPATENT DESCRIBED

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.EFFECTS DESCRIBED ARE FROM A MULTI-COMPONENT RX.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeORAL
OrganismThalictrum aquilegifolium (RANUNCULACEAE)
CitationADACHI,K:. (1973). COMPLEX ANTI-CANCER AGENT.. ()
Amount utilized
Compound isolated
DiseaseA MIXTURE OF USNEA LONGISSIMA, KALOPANAX RICINIFOLIUM, THALICTRUM AQUILEGIFOLIUM, CHRYSANTHEMUM PACIFICUM AND ZINGIBER OFFICINALIS WAS GIVEN TO CANCER PATIENTS.
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractH2O EXT